Cargando…

EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features

BACKGROUND: To evaluate the expression of EGFR and COX-2 and their correlation with prognosis in NSCLC METHODS: The paraffin embedded tumor samples of 50 NSCLC patients receiving radical resection were analyzed immunohistochemically for EGFR and COX-2 expression and their prognostic values were expl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Feng, Liu, Yongmei, Chen, Huijiao, Liao, Dianying, Shen, Yali, Xu, Feng, Wang, Jin
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063193/ https://www.ncbi.nlm.nih.gov/pubmed/21385353 http://dx.doi.org/10.1186/1756-9966-30-27

Ejemplares similares

Correction: EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features
por: Li, Feng, et al.
Publicado: (2011)

Correlation of neuroendocrine features with prognosis of non-small cell lung cancer
por: Feng, Jianguo, et al.
Publicado: (2016)

Transactivation of EGFR by LPS Induces COX-2 Expression in Enterocytes
por: McElroy, Steven J., et al.
Publicado: (2012)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
por: Steendam, Christi M. J., et al.
Publicado: (2020)

The correlation of expression of VEGF and EGFR with SUV of (18)FDG-PET-CT in non-small cell lung cancer
por: Liu, Xiguang, et al.
Publicado: (2014)

HER2 induces cell proliferation and invasion of non-small-cell lung cancer by upregulating COX-2 expression via MEK/ERK signaling pathway
por: Chi, Feng, et al.
Publicado: (2016)

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
por: Saifon, Woraseth, et al.
Publicado: (2022)

Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
por: Pastuszak-Lewandoska, Dorota, et al.
Publicado: (2014)

Adjuvant EGFR-TKI therapy in resected EGFR-mutation positive non-small cell lung cancer: A real-world study
por: Liu, Jun-Feng, et al.
Publicado: (2023)

Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer
por: Wen, Qiuyuan, et al.
Publicado: (2015)

Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer
por: Hao, Zhixing, et al.
Publicado: (2022)

PD-L1 Expression and Outcome in Patients with Metastatic Non-Small Cell Lung Cancer and EGFR Mutations Receiving EGFR-TKI as Frontline Treatment
por: Chang, Cheng-Yu, et al.
Publicado: (2021)

Clinical Features Reflect Exon Sites of EGFR Mutations in Patients with Resected Non-Small-Cell Lung Cancer
por: Na, Im II, et al.
Publicado: (2007)

Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
por: Nakra, Tripti, et al.
Publicado: (2021)

Cyclooxygenase‐2 (COX‐2) mRNA Expression Levels in Normal Lung Tissues and Non‐small Cell Lung Cancers
por: Ochiai, Mari, et al.
Publicado: (1999)

Epidermal Growth Factor Receptor (EGFR) Expression in Operable Non-small Cell Lung Carcinoma
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

COX-2 and EGFR: Partners in Crime Split by Aspirin
por: Patrignani, Paola, et al.
Publicado: (2015)

Correlation of Thyroid Transcription Factor-1 Expression with EGFR Mutations in Non-Small-Cell Lung Cancer: A Meta-Analysis
por: Kim, Hyeong Su, et al.
Publicado: (2019)

Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR ‐mutant non‐small cell lung cancer
por: Lei, Si‐Yu, et al.
Publicado: (2023)

Clinical outcomes of EGFR +/ METamp+ vs. EGFR +/ METamp‐ untreated patients with advanced non‐small cell lung cancer
por: Peng, Kai‐Cheng, et al.
Publicado: (2022)

Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond
por: Delaney, Christopher, et al.
Publicado: (2015)

Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
por: Xia, Guo-Hao, et al.
Publicado: (2014)

Correlation of EGFR G873R mutation with prognosis of docetaxel in non-small cell lung cancer
por: Tian, Yu, et al.
Publicado: (2021)

Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer
por: Park, Silvia, et al.
Publicado: (2015)

Expression of WASF3 in patients with non-small cell lung cancer: Correlation with clinicopathological features and prognosis
por: WU, JIE, et al.
Publicado: (2014)

Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
por: Yi, Yali, et al.
Publicado: (2022)

Polymorphisms, Mutations, and Amplification of the EGFR Gene in Non-Small Cell Lung Cancers
por: Nomura, Masaharu, et al.
Publicado: (2007)

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer
por: Nishii, Teppei, et al.
Publicado: (2014)

Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
por: Lee, Taebum, et al.
Publicado: (2016)

EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases
por: Armocida, Daniele, et al.
Publicado: (2023)

COX7A1 suppresses the viability of human non‐small cell lung cancer cells via regulating autophagy
por: Zhao, Lei, et al.
Publicado: (2019)

Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
por: Crintea, Andreea, et al.
Publicado: (2023)

EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials
por: Wu, Jing-Xun, et al.
Publicado: (2018)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Predictive Factors for Switched EGFR-TKI Retreatment in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
por: Kwon, Byoung Soo, et al.
Publicado: (2017)

Role of PARP1-mediated autophagy in EGFR-TKI resistance in non-small cell lung cancer
por: Zhang, Zhimin, et al.
Publicado: (2020)

Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer
por: Zhang, Shi-Ling, et al.
Publicado: (2023)

Concomitance of P-gp/LRP Expression with EGFR Mutations in Exons 19 and 21 in Non-Small Cell Lung Cancers
por: Wei, Hong, et al.
Publicado: (2016)

Correction: Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
por: Yi, Yali, et al.
Publicado: (2022)

Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications
por: Gou, Hong-Feng, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uoe3c3eoseorqg8j6c8vbkmp6n